摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-((R)-5-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-dihydroxycyclohexylidene)ethylidene)-7a-methyl-octahydro-1H-inden-1-yl)hexyl)methanesulfamide | 1188931-66-9

中文名称
——
中文别名
——
英文名称
N-((R)-5-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-dihydroxycyclohexylidene)ethylidene)-7a-methyl-octahydro-1H-inden-1-yl)hexyl)methanesulfamide
英文别名
N-((R)-5-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-dihydroxycyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)pentyl)methanesulfamide;(1R,3aS,4E,7aR)-4-[2-[(3R,5R)-3,5-dihydroxycyclohexylidene]ethylidene]-7a-methyl-1-[(2R)-5-(sulfamoylamino)pentan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-indene
N-((R)-5-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-dihydroxycyclohexylidene)ethylidene)-7a-methyl-octahydro-1H-inden-1-yl)hexyl)methanesulfamide化学式
CAS
1188931-66-9
化学式
C23H40N2O4S
mdl
——
分子量
440.648
InChiKey
XDFUCQBRVHAWOS-RSRWNDFGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    30
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    121
  • 氢给体数:
    4
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    tert-butyl-N-((R)-4-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-bis(tert-butyldimethylsilyloxy)cyclohexylidene)ethylidene)-7a-methyl-octahydro-7H-inden-1-yl)pentyl)sulfamoylcarbamate 在 氢氟酸 作用下, 以 二氯甲烷乙腈 为溶剂, 以3.2 mg的产率得到N-((R)-5-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-dihydroxycyclohexylidene)ethylidene)-7a-methyl-octahydro-1H-inden-1-yl)hexyl)methanesulfamide
    参考文献:
    名称:
    Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids
    摘要:
    Incorporation of zinc-binding groups into the side-chain of 1 alpha, 25-dihydroxyvitamin D-3 (1,25D) fully bifunctional hybrid molecules which act both as vitamin D receptor agonists and histone deacetylase inhibitors. These bifunctional hybrids display in vitro antiproliferative activity against the AT84 squamous carcinoma cell line while lacking the in vivo hypercalcemic effects of 1,25D. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2010.03.078
点击查看最新优质反应信息

文献信息

  • [EN] HYBRID MOLECULES HAVING MIXED VITAMIN D RECEPTOR AGONISM AND HISTONE DEACETYLASE INHIBITORY PROPERTIES<br/>[FR] MOLÉCULES HYBRIDES ASSOCIANT AUX PROPRIÉTÉS D'AGONISME DU RÉCEPTEUR DE LA VITAMINE D, DES PROPRIÉTÉS D'INHIBITION DE L'HISTONE DÉSACÉTYLASE
    申请人:UNIV MCGILL
    公开号:WO2009117831A9
    公开(公告)日:2009-12-30
  • Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids
    作者:Marc Lamblin、Basel Dabbas、Russell Spingarn、Rodrigo Mendoza-Sanchez、Tian-Tian Wang、Beum-Soo An、Dao Chao Huang、Richard Kremer、John H. White、James L. Gleason
    DOI:10.1016/j.bmc.2010.03.078
    日期:2010.6.1
    Incorporation of zinc-binding groups into the side-chain of 1 alpha, 25-dihydroxyvitamin D-3 (1,25D) fully bifunctional hybrid molecules which act both as vitamin D receptor agonists and histone deacetylase inhibitors. These bifunctional hybrids display in vitro antiproliferative activity against the AT84 squamous carcinoma cell line while lacking the in vivo hypercalcemic effects of 1,25D. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多